Therapeutic Advances in Neurological Disorders (Mar 2011)

Symptomatic therapy in multiple sclerosis

  • Teresa C. Frohman,
  • Wanda Castro,
  • Anjali Shah,
  • Ardith Courtney,
  • Jeffrey Ortstadt,
  • Scott L. Davis,
  • Diana Logan,
  • Thomas Abraham,
  • Jaspreet Abraham,
  • Gina Remington,
  • Katherine Treadaway,
  • Donna Graves,
  • John Hart,
  • Olaf Stuve,
  • Gary Lemack,
  • Benjamin Greenberg,
  • Elliot M. Frohman

DOI
https://doi.org/10.1177/1756285611400658
Journal volume & issue
Vol. 4

Abstract

Read online

Multiple sclerosis is the most common disabling neurological disease of young adults. The ability to impact the quality of life of patients with multiple sclerosis should not only incorporate therapies that are disease modifying, but should also include a course of action for the global multidisciplinary management focused on quality of life and functional capabilities.